New Science Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals
  • Investments
  • 119

  • Portfolio
  • 33

  • Exits
  • 43

Exits

New Science Ventures General Information

Description

Founded in 2004, New Science Ventures is a venture capital firm based in Greenwich, Connecticut. The firm seeks to invest in pharmaceuticals, biotechnology, healthcare devices, healthcare technology systems, consumer durables, life sciences, health tech, information technology, and digital health sectors in the United States, Europe.

Contact Information

Year Founded
2004
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 500 West Putnam Avenue
  • Suite 400
  • Greenwich, CT 06830
  • United States
+1 (212) 000-0000

New Science Ventures Investments (119)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Phase Four 10-Jun-2022 Later Stage VC 000.00 Aerospace and Defense Generating Revenue
0000000 24-May-2022 00000 00000 000.00 Biotechnology Generating Revenue 0000-000000 00000 00.0
0000000 15-May-2022 00000 00000 00.00 Telecommunications Service Providers Generating Revenue
00000000 01-Jan-2022 00000 00000 000.00 Electronic Equipment and Instruments Generating Revenue
00000000 000000000 17-Dec-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000000000000 00000000000
0000000000 06-Dec-2021 00000 00000 000.00 Energy Storage Generating Revenue 000000000000 00000000000
000000000 00000000 02-Nov-2021 00000 00000 000.00 Other Healthcare Technology Systems Generating Revenue 000000000000 00000000000
000 00000 0000000 25-Oct-2021 00000 00000 00000 Aerospace and Defense Generating Revenue
Zeotap 08-Sep-2021 Later Stage VC 000.00 Business/Productivity Software Generating Revenue
Pakal Tech 27-Jul-2021 Early Stage VC 00.000 General Purpose Semiconductors Generating Revenue 000000000000 00000000000
You’re viewing 10 of 119 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

New Science Ventures Exits (43)

Company Name Exit Date Exit Type Exit Size
Ventyx Biosciences 21-Oct-2021 IPO 00000
00 000000 01-Oct-2021 000000000 00000000
0000 00000 15-Sep-2021 000000000 00000000
00000000 000000000 01-Apr-2021 000000000 00000000
0000000 0000000000 09-Mar-2021 000000000000000000
0000000 26-Jan-2021 000000000000000000
00000 000000000000 27-Aug-2020 0000000000
000000000 03-Apr-2020 000000000000000000
Paradigm Diagnostics 03-Mar-2020 Merger/Acquisition
Ario Pharma 01-Oct-2019 Out of Business
You’re viewing 10 of 43 exits. Get the full list »

New Science Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore New Science Ventures‘s full profile, request access.

Request a free trial

New Science Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

New Science Ventures Team (11)

Name Title Deals Funds Boards Office
Brenda Marex Chief Financial Officer New York, NY
Thomas Lavin Co-Founder & Partner 0 0 0 New York, NY
Jean-Pierre Bizet Ph.D Partner & Senior Advisor 0 0 0 New York, NY
Andrew Abrams Partner 0 0 0 London, United Kingdom
Somasundaram Subramaniam Co-Founder & Managing Partner 00 0 00 New York, NY
You’re viewing 5 of 11 team members. Get the full list »

New Science Ventures Co-Investors (123)

Name With Exits Lead Partner Series Industry
BioGeneration Ventures 2 0 Series chart Industry bar
Forbion 0 0 Series chart Industry bar
In-Q-Tel 0 Series chart Industry bar
Société Régionale d'Investissement de Wallonie 0 0 Series chart Industry bar
venBio 0 0 Series chart Industry bar
You’re viewing 5 of 123 co-investors. Get the full list »